MHC
GILD icon

May Hill Capital’s Gilead Sciences GILD Stock Holding History

May Hill Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$339K Buy
2,435
+149
+7% +$20.9K 0.09% 164
2025
Q4 		$281K Buy
2,286
+88
+4% +$10.7K 0.08% 158
2025
Q3 		$244K Buy
2,198
+54
+3% +$6.14K 0.07% 167
2025
Q2 		$238K Buy
2,144
+111
+5% +$11.8K 0.08% 165
2025
Q1 		$228K Buy
+2,033
New +$210K 0.09% 157

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

May Hill Capital's GILD Position: Q1 2026 in Review

May Hill Capital increased its Gilead Sciences (GILD) stake by 6.5% in Q1 2026, buying an estimated $20.9K and bringing the position to 2,435 shares worth $339K. The position accounts for 0.09% of the portfolio, ranked #164.

May Hill Capital first reported a position in GILD in Q1 2025 and has held it in 5 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • May Hill Capital held 2,435 shares of Gilead Sciences worth $339K as of Q1 2026.
  • May Hill Capital bought 149 Gilead Sciences shares in Q1 2026, an estimated $20.9K.
  • Gilead Sciences made up 0.09% of May Hill Capital's portfolio in Q1 2026, its #164 holding.
  • May Hill Capital first reported a position in Gilead Sciences in Q1 2025 and has held it in 5 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on May Hill Capital's 13F filing for Q1 2026, filed 6 May 2026.